In this episode, we look beyond treatment selection and dig into the real reason so many psoriasis therapies fall short: patients stop using them far sooner than clinicians expect.

Dr. Raj Bhardwaj speaks with dermatology expert Dr. Steve Feldman, whose decades of research reveal that adherence isn’t about patient stubbornness—it’s about behavior, accountability, and how we design care.

They unpack practical, evidence-backed strategies that help patients stay on treatment and achieve lasting control.

In this episode, we step back from the exam room and look at plaque psoriasis as a whole-body condition—not just a skin disorder. Dr. Raj Bhardwaj speaks with rheumatologist and clinical epidemiologist Dr. Alexis Ogdie about how systemic inflammation, metabolic risk, and early signs of psoriatic arthritis intersect in ways clinicians can easily miss.

Drs. Bhardwaj and Ogdie explain why recognizing psoriatic disease early and treating it holistically can change a patient’s entire health trajectory.

This episode takes a deeper look at how clinicians navigate the real-world complexity of treating plaque psoriasis, moving far beyond textbook definitions of severity. Dr. Raj Bhardwaj sits down with leading dermatologist Dr. Andrew Blauvelt to unpack how early decisions, evolving guidelines, and patient-centered goals—especially the push for complete clearance—shape long-term outcomes.

Together, they explore why psoriasis is never “just a skin condition” and how thoughtful, individualized care can transform a patient’s quality of life.

“All clear” isn’t always the end. Melanoma’s ability to recur months or years after surgery is shifting how clinicians think about treatment timelines. DDx host Raj Bhardwaj, MD, and Omid Hamid, MD, chief of translational research and immunotherapy at The Angeles Clinic and Research Institute in Los Angeles, explore strategies for identifying patients at high risk for melanoma recurrence, new therapeutic approaches before and after surgery, and what these developments mean for the future of melanoma care.

A young man walks into a hemophilia treatment center. He’s limping, certain his ankle is bleeding again—same as always. But this time, the team discovers the pain may be coming from something else, something that isn’t in the patient’s chart. In this story, we explore the many ways and forms pain can present, and the importance of treating the whole person.

Transitioning hemophilia care from pediatric to adult care sounds simple enough. At home, though, it can be complicated—habits run deep, and for parents of children with hemophilia, the line between protection and independence isn’t always clear. In this episode, we’ll explore how hemophilia treatment centers put transition care into practice to help teens and young adults with bleeding disorders navigate taking ownership of their treatment and their first steps toward independence.